E-Mail To A Friend | View Printable |
Michael L. Linenberger, MD
Resume |
Story
Fred Hutchinson Cancer Research Center
Clinical Research Division, Associate Member
Seattle Cancer Care Alliance
Apheresis and Cellular Therapy, Medical Director
UW Medicine Hematology Specialist
Hematology Division, Associate Professor
We strive to provide compassionate care which emphasizes a partnership with the patient and other providers. This care is delivered in a comprehensive setting utilizing the skills and knowledge of the university medical community.
Therapeutic Apheresis, Marrow and peripheral blood stem cell procurement, AML treatment with antibody-based agents, Hypercoagulable disorders, Iron overload disorders, Porphyrias, Benign and malignant hematologic disorders.
For more information about Dr. Michael L. Linenberger's clinical and research expertise, click here.
Make An AppointmentTo refer a patient, to make an appointment, or get additional information about Seattle Cancer Care Alliance, please contact us directly by telephone, fax, or mail.
Telephone: (206) 288-SCCA (7222) Fax: (206) 288-1025 |
||
Dr. Linenberger cares for people who have anemia, bleeding and thrombotic disorders, low platelets, sickle cell disease, iron overload, myeloma, leukemia, lymphoma, myelodysplasia, and myeloproliferative disorders. Read more about Dr. Linenberger and his work at SCCA.
Title
Fred Hutchinson Cancer Research Center
Clinical Research Division, Associate Member
Seattle Cancer Care Alliance
Apheresis and Cellular Therapy, Medical Director
UW Medicine Hematology Specialist
Hematology Division, Associate Professor
Patient Care Philosophy:
We strive to provide compassionate care which emphasizes a partnership with the patient and other providers. This care is delivered in a comprehensive setting utilizing the skills and knowledge of the university medical community.
Cancer Types / Diagnosis:
- Blood Disorders
- Bone Marrow Transplant
- Myeloproliferative Neoplasms (MPN)
Clinical Expertise:
Therapeutic Apheresis, Marrow and peripheral blood stem cell procurement, AML treatment with antibody-based agents, Hypercoagulable disorders, Iron overload disorders, Porphyrias, Benign and malignant hematologic disorders.
Education And Training:
- University of Kansas Medical School, 1982
- Residency: Rhode Island Hospital, Department of Medicine 1982-1985
- Fellowship: University of Washington, Division of Hematology 1986-1989
More Information:
For more information about Dr. Michael L. Linenberger's clinical and research expertise, click here.
Michael L. Linenberger
